Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
InVivo Therapeutics Holdings Corp
(OB:
NVIV
)
1.580
USD
UNCHANGED
Last Price
/ Updated:
8:10 PM EDT, Sep 25, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
2.150 (500)
Ask (Size)
2.520 (500)
Prev. Close
1.580
Today's Range
1.580 - 1.580
52wk Range
0.9400 - 6.200
Shares Outstanding
78,577,431
Dividend Yield
N/A
Performance
YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+0.64%
+0.64%
1 Year
-31.00%
-31.00%
Top News
More News
TrendingWallStreet.com Initiates Trend Alerts on CSCO, CLF, NVIV, and ZNGA
December 30, 2013
from
ACCESSWIRE
InVivo Therapeutics Names Thomas R. Ulich, MD as Its New Chief Scientific Officer
February 24, 2014
from
Business Wire News Releases
More News
Read More
InVivo Sends Amended Protocol to FDA and Six Clinical Sites
January 03, 2014
from
Business Wire News Releases
News and Updates on CTIX, CERP, NVIV and TRTC
November 12, 2013
from
ACCESSWIRE
InVivo Announces Regulatory and Clinical Promotions
December 27, 2013
from
Business Wire News Releases
InVivo Therapeutics to Move Forward with Its First Clinical Trial After Receiving FDA Conditional Approval
December 26, 2013
from
Business Wire News Releases
InVivo Names Mark Perrin as Its New Chief Executive Officer
December 23, 2013
from
Business Wire News Releases
InVivo Therapeutics Appoints Steven McAllister as Interim CFO
December 16, 2013
from
Business Wire News Releases
InVivo Therapeutics Announces Promotions in Technical Operations
December 09, 2013
from
Business Wire News Releases
InVivo Therapeutics Appoints Christopher McNulty as Vice President, Business Development
November 18, 2013
from
Business Wire News Releases
InVivo Therapeutics Lead Program on Track
November 15, 2013
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here